Abstract:Morpholino and cyanomorpholino derivatives of the anthracycline antitumor antibiotics, Adriamycin (ADM) and daunomycin (DNM), differ from their parent compounds in potency, cross-resistance and other biological properties. We therefore investigated the DNA interactions of several derivatives of ADM and DNM, including iminomorpholinoadriamycin, oxazolocyanomorpholinoadriamycin, (OCADM), and cyanomethyladriamycin (CMeADM). This work complements previous studies on morpholinodaunomycin (MoDNM), morpholinoadriamycin (MoADM), and cyanomorpholinoadriamycin (CNMoADM). As described in this work, unscheduled DNA synthesis is induced by iminomorpholinoadriamycin, 5-iminocyanomorpholinoadriamycin (ICADM), OCADM, and CMeADM but not by ADM and DNM. In addition, we observed the induction of DNA single-strand breaks by ICADM, OCADM, and CMeADM in V79 cells; previous work has shown that ADM and DNM but not MoDNM induce single-strand breaks in these cells. DNA cross-links were induced by ICADM at high concentrations (greater than 50 nM) but not by MoADM, OCADM, and CMeADM as described herein. In previous investigations, we observed that CNMoADM and cyanomorpholinodaunomycin (CNMoDNM) but not ADM, DNM, and MoDNM induce DNA cross-links. CNMoADM and CNMoDNM are the most potent cytotoxic derivatives of ADM and DNM and have their cross-linking potential in common. The fact that CNMoADM and CNMoDNM (as well as ICADM at higher concentrations) all contain an alpha-cyanamide functionality and also yield cross-links suggests that this functionality is important for cross-linking. The CN moiety in [14C]N-MoADM was shown to be lost during the reaction with DNA and rat liver S9 (but not with buffer), which suggests that adduction via CN displacement is possible. On the other hand, OCADM and CMeADM both contain the alpha-cyanamine functionality but have a modified morpholino ring and do not yield cross-links. This suggests that an intact morpholino ring, which is metabolized to a reactive form, is necessary for cross-linking. A number of metabolites from MoDNM treated with rat liver S9 mix were isolated. These products, when analyzed by gas chromatography-mass spectrometry, are consistent with metabolism in the morpholino ring; however, definitive structural assignments could not yet be made.

Complexation of anthracycline drugs with DNA in the presence of caffeine

Synergistic effect of the combination of nanoparticulate Fe3O4 and Au with daunomycin on K562/A02 cells.

DOX-DNA Interactions on the Nanoscale: In Situ Studies Using Tip-Enhanced Raman Scattering

Anthracyclines React with Apurinic/Apyrimidinic Sites in DNA

The interaction of proanthocyanidins with DNA molecules studied by atomic force microscopy and spectroscopic method

Mechanistic aspects of DNA damage by morpholinyl and cyanomorpholinyl anthracyclines

Unveiling the multifaceted interactions of antitumor drug mitoxantrone with ct-DNA through biophysical and in silico studies

Spectroscopic and cytotoxicity studies on the combined interaction of (−)-epigallocatechin-3-gallate and anthracycline drugs with human serum albumin

Crystal Structures, Interactions with Biomacromolecules and Anticancer Activities of Mn(II), Ni(II), Cu(II) Complexes of Demethylcantharate and 2-Aminopyridine

Interactions Between Dna And The Acridine Intercalator: A Computational Study

Crystal Structures, Dna Interaction and Growth Inhibitory Activities of the Cobalt(Ii) and Nickel(Ii) Complexes of 2-Aminothiazole with Demethylcantharate

Thermodynamic and cellular studies of doxorubicin/daunorubicin loaded by a DNA tetrahedron for diagnostic imaging, chemotherapy, and gene therapy

Interactions of a Novel Anthracycline with Oligonucleotide DNA and Cyclodextrins in an Aqueous Environment

Calculation of the Binding Affinity of the Anticancer Drug Daunomycin to DNA by a Statistical Mechanics Approach

Effects of pH on the kinetics of the interaction between anthracyclines and lipid bilayers

Understanding enhanced mechanical stability of DNA in the presence of intercalated anticancer drug: Implications for DNA associated processes

Monitoring Anthracycline Cancer Drug–Nucleosome Interaction by NMR using a Specific Isotope Labeling Approach for Nucleosomal DNA

The Interaction between DNA and Three Intercalating Anthracyclines Using Electrochemical DNA Nanobiosensor Based on Metal Nanoparticles Modified Screen-Printed Electrode

Understanding prodrugs: complexation in aqueous solutions of doxorubicin, bovine serum albumin and gold nanoparticles

Cancer-Targeted Controlled Delivery of Chemotherapeutic Anthracycline Derivatives Using Apoferritin Nanocage Carriers

Interaction of Calf Thymus DNA with the Ni(II) Complex of Sodium 1,4-Dihydroxy-9,10-Anthraquinone-2-Sulphonate: A Novel Method of Analysis Using Cyclic Voltammetry